scholarly journals Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

2019 ◽  
Vol 38 (1) ◽  
Author(s):  
Luigi Mele ◽  
Marcella la Noce ◽  
Francesca Paino ◽  
Tarik Regad ◽  
Sarah Wagner ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor ◽  
Glucose 6 Phosphate Dehydrogenase

scholarly journals ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells

2011 ◽  
Vol 132 (1) ◽  
pp. 109-119 ◽  
Author(s):  
Katherine M. Aird ◽  
Jennifer L. Allensworth ◽  
Ines Batinic-Haberle ◽  
H. Kim Lyerly ◽  
Mark W. Dewhirst ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Oxidative Stress ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Inflammatory Breast Cancer ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor ◽  
Induced Apoptosis

scholarly journals A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells

2012 ◽  
Vol 318 (16) ◽  
pp. 2014-2021 ◽  
Author(s):  
Courtney R. Giordano ◽  
Kelly L. Mueller ◽  
Laura J. Terlecky ◽  
Kendra A. Krentz ◽  
Aliccia Bollig-Fischer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor

scholarly journals Astemizole, an Inhibitor of Ether-�-Go-Go-1 Potassium Channel, Increases the Activity of the Tyrosine Kinase Inhibitor Gefitinib in Breast Cancer Cells

2019 ◽  
Vol 71 (3) ◽  
Author(s):  
Janice García-Quiroz ◽  
María E. González-González ◽  
Lorena Díaz ◽  
David Ordaz-Rosado ◽  
Mariana Segovia-Mendoza ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Potassium Channel ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

2012 ◽  
Vol 23 (3) ◽  
pp. 288-297 ◽  
Author(s):  
Hye Jin Kim ◽  
Hwang-Phill Kim ◽  
Young-Kwang Yoon ◽  
Maeng-Sup Kim ◽  
Gwan-Sun Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Antitumor Activity ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

2006 ◽  
Vol 102 (3) ◽  
pp. 275-282 ◽  
Author(s):  
Monica R. Maiello ◽  
Amelia D’Alessio ◽  
Antonella De Luca ◽  
Adele Carotenuto ◽  
Anna Maria Rachiglio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor ◽  
Intrinsic Resistance ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

2006 ◽  
Vol 207 (2) ◽  
pp. 420-427 ◽  
Author(s):  
Nicola Normanno ◽  
Antonella De Luca ◽  
Monica R. Maiello ◽  
Manuela Campiglio ◽  
Maria Napolitano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor ◽  
Mapk Pathway ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document